Vistin Pharma ASA
VP4
Company Profile
Business description
Vistin Pharma ASA is a Norway based pharmaceutical company. It is principally engaged in the business activity of producing active pharmaceutical ingredients (APIs) and solid dosage forms for the pharmaceutical industry. The company has two business segments namely Pharmaceuticals and Energy Trading. The group has operations in Norway, Germany, Switzerland, Great Britain, Algeria and other countries.
Contact
Ostensjoveien 27
P.O. Box 6735 Etterstad
Oslo0661
NORT: +47 35984200
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
75
Stocks News & Analysis
stocks
Magellan merger modestly dilutive
Our view on how shareholders should respond to the Magellan merger.
stocks
ASX listed gold miner under pressure due to lower production
Shares have dropped nearly 20% since lowering 2026 volume guidance.
stocks
3 ASX opportunities after earnings season
Uncovering key opportunities following February’s results.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,847.70 | 14.20 | 0.16% |
| CAC 40 | 7,967.31 | 7.18 | -0.09% |
| DAX 40 | 23,581.87 | 149.05 | -0.63% |
| Dow JONES (US) | 46,993.26 | 46.85 | 0.10% |
| FTSE 100 | 10,329.89 | 73.71 | -0.71% |
| HKSE | 26,025.42 | 156.88 | 0.61% |
| NASDAQ | 22,479.53 | 105.35 | 0.47% |
| Nikkei 225 | 55,239.40 | 1,539.01 | 2.87% |
| NZX 50 Index | 13,315.60 | 133.37 | 1.01% |
| S&P 500 | 6,716.09 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,640.60 | 14.40 | 0.17% |
| SSE Composite Index | 4,062.98 | 13.08 | 0.32% |